"Polypharmacy Risks: How Too Many Prescriptions Increase Fatal Falls in Older Adults"

The Hidden Danger of Polypharmacy: How Too Many Prescriptions Are Fueling a Surge in Fatal Falls Among Older Adults

Berlin, Germany—For many older adults, a simple stumble can turn deadly. Over the past three decades, the risk of death following a fall has tripled in the United States, a trend that experts increasingly attribute not to aging alone, but to a silent epidemic: polypharmacy—the simultaneous use of five or more prescription medications. While each drug may be medically justified on its own, their combined effects can lead to dizziness, confusion, and impaired balance, turning a routine misstep into a life-threatening event.

New research published in BMC Geriatrics and commentary in JAMA highlight a troubling paradox: the very medications meant to improve health in older adults may be putting them at greater risk. “There is plenty of reason to believe that the surge in fall deaths may be tied to the soaring use of certain prescription drugs,” writes Dr. Thomas A. Farley, a Washington, D.C.–based public health expert, in JAMA. The problem is not limited to the U.S. In Finland, a longitudinal study of long-term care residents found that those taking five or more medications were significantly more likely to experience falls, injuries, and even premature death over a three-year period.

Yet despite growing evidence, polypharmacy remains a largely overlooked public health crisis. With nearly 40% of older adults in the U.S. Taking five or more prescription drugs, and similar trends observed in Europe, the question is no longer whether polypharmacy increases fall risk—but what can be done to reverse the trend.

What Is Polypharmacy—and Why Is It So Dangerous?

Polypharmacy is typically defined as the regular use of five or more medications, though some researchers classify “excessive polypharmacy” as taking more than 10. While the term may sound technical, its consequences are anything but. The Centers for Disease Control and Prevention (CDC) identifies a category of drugs known as Fall Risk-Increasing Drugs (FRIDs), which include:

• Beta-blockers (used for heart conditions and high blood pressure)
• Anticholinergics (prescribed for allergies, depression, and bladder control issues)
• Gabapentinoids (used to treat nerve pain and seizures)
• Proton pump inhibitors (commonly prescribed for acid reflux)
• Benzodiazepines (sedatives often used for anxiety or insomnia)

These medications can cause drowsiness, slowed reaction times, low blood pressure, and balance problems—all of which increase the likelihood of a fall. Even drugs not traditionally considered high-risk, like proton pump inhibitors, may weaken bones over time, making fractures more likely if a fall occurs.

A 2023 study in BMC Geriatrics tracked 2,000 long-term care residents in Finland and found that those taking five to nine medications had a 30% higher risk of falls compared to those taking fewer than five. For residents taking more than 10 medications, the risk doubled. The study also linked polypharmacy to a 25% increase in mortality over three years, even after adjusting for underlying health conditions.

The Alarming Rise in Fall-Related Deaths

The statistics are stark. In the U.S., fall-related deaths among adults aged 65 and older have risen from 8,600 in 1999 to nearly 36,500 in 2021—a more than fourfold increase. While some of this rise can be attributed to an aging population, experts argue that lifestyle changes alone cannot explain the surge. “Cutting back on unnecessary FRIDs could be a simple but powerful way to reduce fall rates and help seniors remain safe, independent, and active as they age,” the authors of the BMC Geriatrics study concluded.

Dr. Farley’s JAMA commentary points to a troubling trend: the use of FRIDs has grown dramatically over the past 20 years. For example, prescriptions for gabapentinoids nearly tripled between 2002 and 2015, while benzodiazepine use among older adults remains high despite known risks. Many of these drugs are prescribed for chronic conditions that could often be managed with lifestyle changes, physical therapy, or lower-risk alternatives.

Who Is Most at Risk?

While polypharmacy affects people of all ages, older adults are particularly vulnerable due to:

• Age-related changes in metabolism: The liver and kidneys become less efficient at processing medications, leading to higher drug concentrations in the bloodstream.
• Multiple chronic conditions: Conditions like diabetes, heart disease, and arthritis often require multiple medications, increasing the risk of drug interactions.
• Cognitive decline: Memory issues can lead to missed doses or accidental double-dosing, further destabilizing balance and coordination.
• Muscle weakness: Many older adults experience sarcopenia (age-related muscle loss), making it harder to recover from a stumble.

Women are also at higher risk than men, partly because they live longer and are more likely to be prescribed multiple medications. In the U.S., women account for nearly 70% of fall-related deaths among older adults.

What Can Be Done? A Call for “Deprescribing”

The solution, experts say, lies in a practice called deprescribing—the systematic review and reduction of unnecessary or harmful medications. A growing body of research supports deprescribing as a safe and effective way to reduce fall risk without compromising health outcomes.

Key strategies include:

• Regular medication reviews: The Agency for Healthcare Research and Quality (AHRQ) recommends that older adults have their medications reviewed at least once a year by a pharmacist or physician. This is especially critical after hospitalizations, when new drugs are often added without removing aged ones.
• Prioritizing non-drug therapies: For conditions like mild hypertension, insomnia, or chronic pain, lifestyle changes (diet, exercise, physical therapy) can often reduce or eliminate the need for medication.
• Using tools to assess fall risk: The CDC’s STEADI (Stopping Elderly Accidents, Deaths & Injuries) initiative provides screening tools to help healthcare providers identify patients at high risk of falls.
• Patient and caregiver education: Many older adults—and even some doctors—are unaware of the risks associated with polypharmacy. Public health campaigns, like those run by the U.S. Food and Drug Administration (FDA), aim to raise awareness about the dangers of overmedication.

In Finland, the BMC Geriatrics study found that residents whose medication regimens were simplified saw a 20% reduction in falls within 12 months. Similar results have been observed in Canada, where deprescribing initiatives have led to fewer hospitalizations and improved quality of life for older adults.

The Role of Healthcare Systems and Policy

While individual action is important, systemic changes are needed to address polypharmacy at scale. Some promising developments include:

• Electronic health record (EHR) alerts: Some hospitals now use EHR systems to flag high-risk drug combinations or excessive prescriptions for older patients.
• Pharmacist-led interventions: In the U.K., the NHS Medicines Optimisation program embeds pharmacists in primary care settings to review medication regimens and recommend adjustments.
• Policy incentives: In 2023, the U.S. Centers for Medicare & Medicaid Services (CMS) began penalizing Medicare Part D plans that fail to address overprescribing of high-risk drugs like opioids and benzodiazepines.
• Public reporting: Some countries, including Australia, now publicly report polypharmacy rates by hospital and region, creating transparency and accountability.

However, barriers remain. Many doctors face time constraints during appointments, making it difficult to conduct thorough medication reviews. Patients may resist deprescribing due to fear of symptom recurrence or distrust of their provider’s recommendations.

What You Can Do: A Checklist for Safer Medication Use

If you or a loved one is taking multiple medications, here are steps to reduce fall risk:

1. Ask for a “brown bag” review: Bring all medications (prescription, over-the-counter, and supplements) to your next doctor’s appointment and ask for a comprehensive review.
2. Question the necessity of each drug: For each medication, ask: Is this still needed? Are there non-drug alternatives? What are the risks of continuing vs. Stopping?
3. Monitor for side effects: Preserve a journal of any dizziness, confusion, or balance issues, and report them to your doctor.
4. Simplify dosing schedules: Ask your pharmacist if medications can be consolidated (e.g., combining two pills into one).
5. Stay active: Strength and balance exercises, like tai chi or yoga, can reduce fall risk by up to 43%.
6. Fall-proof your home: Remove tripping hazards, install grab bars in bathrooms, and ensure adequate lighting.

The Path Forward: A Global Challenge

Polypharmacy is not just a problem in wealthy nations. As access to healthcare expands globally, so too does the use of prescription medications. In low- and middle-income countries, where regulatory oversight may be weaker, the risks of overmedication are even greater. The World Health Organization (WHO) has identified medication safety as a global priority, calling for better training for healthcare providers and stronger systems to monitor drug use.

For now, the most immediate solution lies in awareness and action. “We have the tools to reduce polypharmacy and its devastating consequences,” says Dr. Hanna-Maria Roitto, lead author of the BMC Geriatrics study. “What we need is the will to implement them.”

Key Takeaways

• Polypharmacy—the use of five or more medications—significantly increases the risk of falls, injuries, and death among older adults.
• Fall-related deaths in the U.S. Have tripled over the past 30 years, with prescription drugs playing a major role.
• Common fall risk-increasing drugs (FRIDs) include beta-blockers, anticholinergics, gabapentinoids, and benzodiazepines.
• Deprescribing—systematically reducing unnecessary medications—can lower fall risk by up to 20%.
• Regular medication reviews, non-drug therapies, and patient education are critical to addressing polypharmacy.

What’s Next?

The next major step in addressing polypharmacy will likely come from policy changes. In the U.S., the FDA is expected to release updated guidelines on medication safety for older adults later this year. Meanwhile, the WHO is working with countries to implement global medication safety standards, with a focus on reducing overprescribing.

For individuals, the message is clear: don’t wait for a fall to take action. If you or a loved one is taking multiple medications, schedule a medication review today. The life you save could be your own.

Have you or a loved one experienced a fall linked to medication use? Share your story in the comments below, and help raise awareness about this critical issue.